Status:

UNKNOWN

Closed Incisional Negative Pressure Wound Therapy in Post-surgical Wound Care of Patients With Periprosthetic Joint Infection

Lead Sponsor:

Chang Gung Memorial Hospital

Conditions:

Wound Heal

Periprosthetic Joint Infection

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

In the proposed study, we will apply Prevena on the surgical wound right after closure of the wound in the operating theater. Prevena will be used for 7 days, unless there is ongoing infection or much...

Eligibility Criteria

Inclusion

  • patients with periprosthetic joint infection
  • indicated for debridement surgery
  • high risk for wound complication, including one of the followings: diabetes mellitus, use anticoagulants other than aspirin, current smoker, on immunomodulators or steroids, malnutrition, liver disease, renal failure, BMI \> 35 kg/m2

Exclusion

  • previous flap surgery on the indexed joint
  • younger than 18 years of age
  • silver allergy

Key Trial Info

Start Date :

March 15 2022

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 31 2024

Estimated Enrollment :

70 Patients enrolled

Trial Details

Trial ID

NCT05357287

Start Date

March 15 2022

End Date

December 31 2024

Last Update

May 2 2022

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Chang Gung Memorial Hospital

Taoyuan District, Taiwan, 333

Closed Incisional Negative Pressure Wound Therapy in Post-surgical Wound Care of Patients With Periprosthetic Joint Infection | DecenTrialz